data_binary_code_2 - usedA new study recently reviewed and analyzed 1.1 million anonymized, de-identified patient records that were managed using the Practice Fusion platform, a cloud-based electronic health record platform for doctors and patients.

Conducted by researchers from Stanford University and Houston Methodist, the study concluded that acid reflux medications, which include common medications such as Prilosec OTC and Prevacid, may be associated with an increase in the risks of patients’ having heart attacks.

Acid reflux medications are the third most commonly taken medication, used by nearly 1 in 14 Americans, according to FDA.

“With over 100 million patient records currently under management, the power of using de-identified data from the Practice Fusion platform to effectively gauge clinical trials, years after they’ve concluded, is unprecedented,” said Ryan Howard, chief executive of Practice Fusion. “With this latest published medical discovery, Practice Fusion is delivering on our commitment to save lives by leveraging EHR data to push the science of medicine forward.”

Published in PLoS One, “Proton pump inhibitor usage and the risk of myocardial infarction in the general population” included lead author Nigam H. Shah, along with Paea LePendu, Anna Bauer-Mehren, Yohannes T. Ghebremariam, Srinivasan V. Iyer, Jake Marcus, Kevin T. Nead, John P. Cooke, and Nicholas J. Leeper.